// App-Quantinova.ai

851 : Liver X Receptor (LXR) Is a Novel and Reversible Regulator of Trauma-Induced Coagulopathy

Researchers

Presenter

  • Peter Einersen

Principal Investigators

  • Reid Selby

  • Ernest E. Moore

  • Marguerite Kelher

  • Miguel Fragoso

  • Daran Schiller

  • Megan Swope

  • Geoffrey Nunns

  • Navin Vigneshwar

  • James Chandler

  • Arsen Ghasabayan

  • John Desisto

  • Bridget Sanford

  • Monika Dzieciatkowska

  • Linda Johnson

  • Mitchell J. Cohen

  • Angelo DAlessandro

  • Erik Peltz

  • Anirban Banerjee

  • Kirk Hansen

  • Christopher C. Silliman

  • Kenneth Jones

Medical Centers

  • Department of Surgery/Trauma Research Center,, University of Colorado School of Medicine, Aurora, CO

  • University of Oklahoma Health Sciences Center, Harold Hamm Diabetes Center, Oklahoma City, OK

  • Surgery, Denver Health Medical Center, Denver, CO

  • Univ of Colorado Denver/Bonfils Blood Center, Denver, CO

  • University of Colorado Cancer Center, Aurora, CO

  • Ernest E Moore Shock Trauma Center, Denver Health Medical Center, Denver, CO

  • Department of Surgery/Trauma Research Center,, University of Colorado School of Medicine, Aurora, CO

  • Department of Pathology, University of Colorado School of Medicine, Aurora, CO

  • Department of Pathology, University of Colorado School of Medicine, Aurora, CO

  • University of Colorado Hospital, Aurora, CO

  • Denver Health Medical Center/ University of Colorado, Denver, CO

  • Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO

  • University of Colorado Cancer Center, Aurora, CO

  • Surgery, School of Medicine, University of Colorado Denver, Aurora, CO

  • U C Denver, Aurora, CO

  • Research, Bonfils Blood Center, Denver, CO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Trauma

Biomarkers

  • Aryl hydrocarbon receptor nuclear translocator-like protein 1

Drug/Treatment

  • Tigason

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A